Close X
Monday, November 25, 2024
ADVT 
Health

Indian-American Researchers Unleash Turmeric’s Power To Fight Cancer

IANS, 13 Aug, 2018 12:35 PM
    A team of Indian-American researchers at the University of Illinois at Urbana-Champaign (UIUC) and at the University of Utah at Salt Lake City, has used an ingenious process to enable curcumin to kill cancer cells.
     
     
    Curcumin is the active ingredient of turmeric (haldi), the ubiquitous kitchen spice that gives curry its yellow color. Turmeric has been used in India for thousands of years as a spice and medicinal herb because of its powerful anti-inflammatory and strong antioxidant property.
     
     
    Curcumin is also known to exhibit anti-cancer properties, but its poor solubility in water had impeded curcumin's clinical application in cancer. A drug needs to be soluble in water as otherwise it will not flow through the bloodstream.
     
     
    Despite decades of research, the development of efficient strategies that can effectively deliver poorly water-soluble curcumin to cancer cells had remained a challenge.
     
     
    A team headed by Dipanjan Pan, associate professor of bioengineering at UIUC, has now found a way out.
     
     
    "Curcumin's medicinal benefit can be fully appreciated if its solubility issue is resolved," Pan told this correspondent in an e-mail.
     
     
    Pan's laboratory collaborated with Peter Stang at the University of Utah on ways to be able to render curcumin soluble, deliver it to infected tumors and kill the cancer cells.
     
     
    Because platinum is a commonly used cancer therapeutic agent in the clinic, the researchers decided to experiment with a drug consisting of a combination of platinum and curcumin.
     
     
    "It is a combination of clever chemistry and nano-precipitation utilising host guest chemistry," Pan explained. "The sophisticated chemistry leads to self-assembled hierarchical structure that drives the solubility of curcumin and simultaneously delivers an additional anticancer agent, i.e. platinum. The combined therapeutic effect -- of curcumin and platinum -- is lethal for the cancer cells."
     
     
    The team has reported its work in the "Proceedings of the National Academy of Sciences" in the US.
     
     
    According to their report, the metallocyclic complex created using platinum "not only enabled curcumin's solubility, but proved to be 100 times more effective in treating various cancer types such as melanoma and breast cancer cells than using curcumin and platinum agents separately".
     
     
    "Our results demonstrate that curcumin works completely in sync with platinum and exerts synergistic effect to show remarkable anticancer properties," says the report. "The platinum-curcumin combination kills the cells by fragmenting its DNA."
     
     
    "Extensive animal studies are in progress in my laboratory, including in rodents and pigs," Pan said. His team also hopes to prove that this method will be effective in killing cancer stem cells -- the birth place of cancer cells -- thereby preventing the recurrence of cancer.
     
     
    Pan's team included post-doctoral researcher Santosh Misra at UIUC, and Sougata Datta, Manik Lal Saha, Nabajit Lahiri, Janis Louie, and Peter J. Stang from the University of Utah.

    MORE Health ARTICLES

    Early Stage Breast Cancer Patients Getting Too Many Imaging Tests: Study

    Early Stage Breast Cancer Patients Getting Too Many Imaging Tests: Study
    Guidelines say that women diagnosed with Stage 1 or Stage 2 breast cancer don't need additional MRIs or CT scans because the risk that their cancer has spread is very low.

    Early Stage Breast Cancer Patients Getting Too Many Imaging Tests: Study

    15 Per Cent Of Kids Who Have An Anaphylactic Reaction Have Delayed 2nd Reaction

    15 Per Cent Of Kids Who Have An Anaphylactic Reaction Have Delayed 2nd Reaction
    TORONTO — A new study suggests about 15 per cent of children who have a severe allergic reaction that involves anaphylaxis can actually have a second reaction hours after the first.

    15 Per Cent Of Kids Who Have An Anaphylactic Reaction Have Delayed 2nd Reaction

    Commercialisation Of Yoga: Boon Or Bane?

    Commercialisation Of Yoga: Boon Or Bane?
    While commercialisation has surged the popularity of yoga, glamourising it to suit modern taste, this has also taken away the authenticity of the age-old discipline, say experts.

    Commercialisation Of Yoga: Boon Or Bane?

    Sex Does Not Hurt Your Back: Study

    Sex Does Not Hurt Your Back: Study
    Could sexual activity trigger lower back pain? No, says a new study that lays the greater blame on heavy lifting.

    Sex Does Not Hurt Your Back: Study

    Stressed, Depressed Women Live Shorter

    Stressed, Depressed Women Live Shorter
    Providing a new possible link between the mind and body, a study says women under chronic stress have significantly lower levels of klotho, a hormone that regulates aging and enhances cognition.

    Stressed, Depressed Women Live Shorter

    Eat Nuts To Cut Cancer Risk: Study

    Eat Nuts To Cut Cancer Risk: Study
    Consuming nuts is associated with a decreased risk of certain types of cancer, but not Type-2 diabetes, says new study.

    Eat Nuts To Cut Cancer Risk: Study